BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15090969)

  • 21. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
    Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA
    Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells.
    Date M; Fukuchi K; Morita S; Takahashi H; Ohura K
    Liver Int; 2003 Dec; 23(6):460-6. PubMed ID: 14986820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
    Collin M; Rossi A; Cuzzocrea S; Patel NS; Di Paola R; Hadley J; Collino M; Sautebin L; Thiemermann C
    J Leukoc Biol; 2004 Nov; 76(5):961-70. PubMed ID: 15328337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure.
    Chatterjee PK; Patel NS; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Britti D; Eberhardt W; Pfeilschifter J; Thiemermann C
    Cardiovasc Res; 2004 Feb; 61(3):630-43. PubMed ID: 14962493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock.
    Zacharowski K; Berkels R; Olbrich A; Chatterjee PK; Cuzzocrea S; Foster SJ; Thiemermann C
    Crit Care Med; 2001 Aug; 29(8):1599-608. PubMed ID: 11505136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.
    Diab A; Deng C; Smith JD; Hussain RZ; Phanavanh B; Lovett-Racke AE; Drew PD; Racke MK
    J Immunol; 2002 Mar; 168(5):2508-15. PubMed ID: 11859145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
    Bernardo A; Ajmone-Cat MA; Levi G; Minghetti L
    J Neurochem; 2003 Nov; 87(3):742-51. PubMed ID: 14535956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.
    Kaplan JM; Cook JA; Hake PW; O'Connor M; Burroughs TJ; Zingarelli B
    Shock; 2005 Jul; 24(1):59-65. PubMed ID: 15988322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R; Mitchell SH; Tindall DJ; Young CY
    Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid reduces the organ injury caused by endotoxemia-a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma.
    Murch O; Collin M; Thiemermann C
    Shock; 2007 Jan; 27(1):48-54. PubMed ID: 17172980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
    Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
    Chung SW; Kang BY; Kim TS
    Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2).
    Paumi CM; Smitherman PK; Townsend AJ; Morrow CS
    Biochemistry; 2004 Mar; 43(8):2345-52. PubMed ID: 14979731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
    Kimura H; Li X; Torii K; Okada T; Takahashi N; Fujii H; Ishihara S; Yoshida H
    Nephrol Dial Transplant; 2008 Aug; 23(8):2496-503. PubMed ID: 18367541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible involvement of 15-deoxy-Δ(12,14) -prostaglandin J2 in the development of leptin resistance.
    Hosoi T; Matsuzaki S; Miyahara T; Shimizu K; Hasegawa Y; Ozawa K
    J Neurochem; 2015 May; 133(3):343-51. PubMed ID: 25662180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.